Abstract
Summary
The global life science instrumentation market is projected to reach USD 73.9 billion by 2028 from USD 54.9 billion in 2023, at a CAGR of 6.1% from 2023 to 2028. Factors such as increasing funding and grants supporting research and development, rising proteomics research, and increasing prevalence of life-threatening diseases are responsible for the increasing growth of this market.
“The spectroscopy segment held the largest share of the market in 2022”
Based on technology, the life science instrumentation market is segmented into spectroscopy chromatography, PCR, immunoassays, lyophilization, liquid handling systems, clinical chemistry analyzers, microscopy, flow cytometry, NGS, centrifuges, electrophoresis, cell counting, and other technologies. The spectroscopy segment held the largest market share in 2022. The large share of this segment can be attributed to the launch of technologically advanced products and rising application in F&B to ensure quality of food products.
“The research applications segment is projected to register the highest CAGR during the forecast period”
Based on application, the life science instrumentation market is segmented into research applications, clinical & diagnostic applications, and other applications. The research applications segment is projected to register the highest CAGR from 2023 to 2028. Factors such as the rising use of life science equipment for disease diagnosis, cancer research, and increasing fundings to support research are driving the market growth.
“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
The life science instrumentation market in the APAC region is expected to register a CAGR during the forecast period, primarily due to the rising use of life science instruments by the applied industries and increasing focus of major players in the region.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: C-level–10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
The prominent players in the life science instrumentation market are Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), and Hitachi High-Technologies Corporation (Japan).
Research Coverage
This report studies the life science instrumentation market based on technology, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall life science instrumentation market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
• Analysis of key drivers (rising food safety concerns, growing investments in pharmaceutical R&D, increasing prevalence of infectious diseases), restraints (shortage of skilled professionals, high cost of instruments), opportunities (increasing demand for analytical tools in emerging countries, growing pharmaceutical and biotechnology industries, and rising opportunities in emerging countries), and challenges (inadequate infrastructure in emerging countries for research, ethical issues related to privacy of data generated from instruments/software) influencing the growth of the life science instrumentation market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the life science instrumentation market
• Market Development: Comprehensive information about lucrative markets–the report analyses the life science instrumentation market across varied regions
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the life science instrumentation market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan).
Table of Contents
1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 41
1.2.1 INCLUSIONS AND EXCLUSIONS 42
1.3 MARKET SEGMENTATION 43
1.3.1 MARKETS COVERED 43
1.3.2 GEOGRAPHICAL SCOPE 44
1.4 YEARS CONSIDERED 44
1.5 CURRENCY CONSIDERED 44
1.6 RESEARCH LIMITATIONS 45
1.7 STAKEHOLDERS 45
1.8 SUMMARY OF CHANGES 46
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH APPROACH 47
2.1.1 SECONDARY RESEARCH 48
2.1.2 PRIMARY RESEARCH 49
- 2.1.2.1 Primary sources 49
- 2.1.2.2 Key industry insights 50
- 2.1.2.3 Breakdown of primaries 50
2.2 MARKET SIZE ESTIMATION 51
2.2.1 BOTTOM-UP APPROACH 52
- 2.2.1.1 Approach 1: Company revenue estimation 53
- 2.2.1.2 Approach 2: Customer-based market estimation 53
- 2.2.1.3 Growth forecast 54
- 2.2.1.4 CAGR projection analysis 55
2.3 DATA TRIANGULATION APPROACH 56
2.4 MARKET SHARE ESTIMATION 57
2.5 STUDY ASSUMPTIONS AND RISK ASSESSMENT ANALYSIS 57
2.6 RISK ASSESSMENT 58
2.6.1 IMPACT OF RISK ANALYSIS 58
2.7 GROWTH RATE ASSUMPTIONS 58
2.8 RECESSION IMPACT ANALYSIS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 63
4.1 LIFE SCIENCE INSTRUMENTATION MARKET OVERVIEW 63
4.2 NORTH AMERICA: LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY 64
4.3 ASIA PACIFIC: LIFE SCIENCE INSTRUMENTATION MARKET, BY APPLICATION, 2023 VS. 2028 65
4.4 GEOGRAPHICAL SNAPSHOT OF LIFE SCIENCE INSTRUMENTATION MARKET 65
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
5.2.1 DRIVERS 67
- 5.2.1.1 Rising investments in pharmaceutical R&D 67
- 5.2.1.2 Growing concerns regarding food contamination 67
- 5.2.1.3 Increasing public-private investments in life science research 68
- 5.2.1.4 Rising incidence of infectious diseases and genetic disorders 69
- 5.2.1.5 Technological advancements in NGS platforms 69
- 5.2.1.6 Growing significance of biomolecular analysis 69
- 5.2.1.7 Growing use of capillary electrophoresis with mass spectroscopy 70
- 5.2.1.8 Increasing adoption of flow cytometry techniques in research laboratories 70
- 5.2.1.9 Rising incidence of hospital-acquired infections 71
5.2.2 RESTRAINTS 71
- 5.2.2.1 Premium product pricing for instruments 71
- 5.2.2.2 Shortage of skilled professionals 72
- 5.2.2.3 Technical limitations associated with qPCR and dPCR techniques 72
- 5.2.2.4 High cost of advanced microscopes 73
5.2.3 OPPORTUNITIES 73
- 5.2.3.1 Growth opportunities in emerging economies 73
- 5.2.3.1.1 Rising focus of key players on emerging markets 73
- 5.2.3.1.2 Rising growth in pharmaceutical & biotechnology industries 74
- 5.2.3.2 Broad applications of analytical instruments across industries 75
- 5.2.3.3 Application of NGS in precision medicine and molecular diagnostics 76
- 5.2.3.4 Growing preference for personalized medicine 76
- 5.2.3.1 Growth opportunities in emerging economies 73
5.2.4 CHALLENGES 76
- 5.2.4.1 Inadequate healthcare infrastructure in emerging economies 76
- 5.2.4.2 Data privacy concerns associated with NGS software 76
5.3 INDUSTRY TRENDS 77
5.3.1 RISING FOCUS ON DEVELOPMENT OF MINIATURE INSTRUMENTS 77
5.3.2 INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES 77
5.3.3 COLLABORATIONS BETWEEN ANALYTICAL INSTRUMENT MANUFACTURERS AND RESEARCH-ACADEMIA 78
5.4 PORTER’S FIVE FORCES ANALYSIS 79
5.4.1 THREAT OF NEW ENTRANTS 79
5.4.2 THREAT OF SUBSTITUTES 79
5.4.3 BARGAINING POWER OF SUPPLIERS 79
5.4.4 BARGAINING POWER OF BUYERS 79
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 80
5.5 TRADE ANALYSIS 80
5.6 PATENT ANALYSIS 89
5.7 ECOSYSTEM ANALYSIS 96
5.8 VALUE CHAIN ANALYSIS 96
5.9 SUPPLY CHAIN ANALYSIS 97
5.9.1 PROMINENT COMPANIES 97
5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES 97
5.9.3 END USERS 97
5.10 PRICING TREND ANALYSIS 98
5.11 TECHNOLOGY ANALYSIS 99
5.11.1 HPLC TECHNOLOGY 99
5.11.2 SPECTROSCOPY 100
5.11.3 MICROSCOPY 100
5.11.4 PCR TECHNOLOGY 100
5.12 CASE STUDY ANALYSIS 101
5.12.1 TECHNOLOGICAL CHALLENGES IN CASE 1 101
5.12.2 TECHNOLOGICAL CHALLENGES IN CASE 2 101
5.12.3 INCREASING SALES MODEL IN CASE 3 102
5.13 REGULATORY ANALYSIS 102
5.13.1 US 102
5.13.2 EUROPE 102
5.13.3 ASIA PACIFIC 103
5.13.4 REST OF THE WORLD 103
5.14 KEY CONFERENCES AND EVENTS (2023-2024) 104
6 LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY 105
6.1 INTRODUCTION 106
6.2 SPECTROSCOPY 107
6.2.1 MASS SPECTROMETERS 109
- 6.2.1.1 Rising analytical applications in laboratories to drive segment 109
6.2.2 MOLECULAR SPECTROMETERS 110
- 6.2.2.1 Applications in pathology detection and protein quantification to propel segment 110
6.2.3 ATOMIC SPECTROMETERS 111
- 6.2.3.1 Utilization in environmental testing and industrial chemistry to support segment 111
6.3 CHROMATOGRAPHY 112
6.3.1 LIQUID CHROMATOGRAPHY SYSTEMS 115
- 6.3.1.1 Rising use of LC systems in pharmaceutical processes to drive market 115
6.3.2 GAS CHROMATOGRAPHY SYSTEMS 116
- 6.3.2.1 Separation of volatile organic compounds in pharmaceutical and food & beverage industries to boost market 116
6.3.3 SUPERCRITICAL FLUID CHROMATOGRAPHY SYSTEMS 117
- 6.3.3.1 Advantages of low viscosity and high diffusivity to support market 117
6.3.4 THIN-LAYER CHROMATOGRAPHY SYSTEMS 118
- 6.3.4.1 Rising use of TLC to separate several samples concurrently to aid market 118
6.4 POLYMERASE CHAIN REACTION (PCR) 119
6.4.1 QUANTITATIVE PCR (QPCR) 122
- 6.4.1.1 Increasing adoption of qPCR among researchers and healthcare professionals to drive segment 122
6.4.2 DIGITAL PCR (DPCR) 123
- 6.4.2.1 Ongoing technological developments to drive segment 123
6.5 IMMUNOASSAYS 124
6.5.1 HIGH SENSITIVITY AND ACCURACY OF IMMUNOASSAY TESTS TO AID MARKET 124
6.6 LYOPHILIZATION 125
6.6.1 TRAY-STYLE FREEZE DRYERS 127
- 6.6.1.1 Rising demand for freeze-dried in pharmaceutical industry to propel segment 127
6.6.2 MANIFOLD FREEZE DRYERS 128
- 6.6.2.1 Rising use in laboratories for storage of bottles and vials to drive segment 128
6.6.3 SHELL (ROTARY) FREEZE DRYERS 129
- 6.6.3.1 Rising research for development of food ingredients and biologic molecules to drive segment 129
6.7 LIQUID HANDLING SYSTEMS 130
6.7.1 ELECTRONIC LIQUID HANDLING SYSTEMS 133
- 6.7.1.1 High accuracy and reproducibility benefits in pharmaceutical industry to augment segment 133
6.7.2 AUTOMATED LIQUID HANDLING SYSTEMS 133
- 6.7.2.1 Elimination of cross-contamination and clogging to drive segment 133
6.7.3 MANUAL LIQUID HANDLING SYSTEMS MARKET 134
- 6.7.3.1 Rising use of manual systems by small-scale industries to drive segment 134
6.8 CLINICAL CHEMISTRY ANALYZERS 135
6.8.1 RISING VOLUME OF CLINICAL TESTING PROCEDURES TO DRIVE MARKET 135
6.9 MICROSCOPY 137
6.9.1 OPTICAL MICROSCOPES 140
- 6.9.1.1 Low maintenance costs and ease of use to drive segment 140
6.9.2 ELECTRON MICROSCOPES 141
- 6.9.2.1 Increasing R&D and availability of funds to support segment 141
6.9.3 SCANNING PROBE MICROSCOPES 142
- 6.9.3.1 Rising applications in nanotechnology research to fuel segment 142
6.9.4 OTHER MICROSCOPES 143
6.10 FLOW CYTOMETRY 144
6.10.1 CELL ANALYZERS 146
- 6.10.1.1 Ongoing technological advancements resulting in innovative product launches to fuel market 146
6.10.2 CELL SORTERS 147
- 6.10.2.1 Utilization of cost-efficient cell sorters in core laboratory functions to drive market 147
6.11 NEXT-GENERATION SEQUENCING (NGS) 148
6.11.1 WIDE APPLICATION IN PERSONALIZED MEDICINE FOR CANCER AND GENETIC DISORDERS TO DRIVE MARKET 148
6.12 CENTRIFUGES 150
6.12.1 MICROCENTRIFUGES 152
- 6.12.1.1 Growing use in blood transfusion and biomedical analysis to support segment 152
6.12.2 MULTIPURPOSE CENTRIFUGES 153
- 6.12.2.1 Applications in cell culture and microbiology to propel segment 153
6.12.3 MINICENTRIFUGES 154
- 6.12.3.1 Compact-sized and smooth functioning in clinical & diagnostic applications to support segment 154
6.12.4 ULTRACENTRIFUGES 155
- 6.12.4.1 Routine density and size-gradient separations to support adoption of ultracentrifuges 155
6.13 ELECTROPHORESIS 155
6.13.1 GEL ELECTROPHORESIS SYSTEMS 157
- 6.13.1.1 Rising demand in proteomics research and personalized medicine to support market 157
6.13.2 CAPILLARY ELECTROPHORESIS SYSTEMS 158
- 6.13.2.1 Numerous analytical benefits offered by CE systems to support segment 158
6.14 CELL COUNTING 159
6.14.1 AUTOMATED CELL COUNTERS 162
- 6.14.1.1 Growing focus on research for life-threatening diseases to drive market 162
6.14.2 HEMOCYTOMETERS AND MANUAL CELL COUNTERS 163
- 6.14.2.1 Rising use of manual cell counters over automated cell counters to support market 163
6.15 OTHER TECHNOLOGIES 163
6.15.1 LABORATORY FREEZERS 165
- 6.15.1.1 Rising demand for blood and blood components to drive market 165
- 6.15.1.2 Freezers 166
- 6.15.1.3 Refrigerators 166
- 6.15.1.3.1 Blood bank refrigerators 166
- 6.15.1.3.2 Chromatography refrigerators 167
- 6.15.1.3.3 Explosion-proof refrigerators 167
- 6.15.1.3.4 Flammable material refrigerators 167
- 6.15.1.3.5 Laboratory refrigerators 167
- 6.15.1.3.6 Pharmacy refrigerators 167
- 6.15.1.3.7 Cryopreservation systems 168
6.15.2 HEAT STERILIZATION 168
- 6.15.2.1 Rising incidence of hospital-acquired infections to drive market 168
- 6.15.2.2 Moist heat/Steam sterilization instruments 169
- 6.15.2.3 Dry heat sterilization instrumentation 170
6.15.3 MICROPLATE SYSTEMS 171
- 6.15.3.1 Wide applications in several industries to support market growth 171
- 6.15.3.2 Microplate readers 172
- 6.15.3.3 Microplate dispensers 173
- 6.15.3.4 Microplate washers 173
6.15.4 LABORATORY BALANCES 173
- 6.15.4.1 Increasing adoption of laboratory balances due to technical benefits to support market growth 173
6.15.5 COLORIMETERS 174
- 6.15.5.1 Low price and ease of operation to support market 174
6.15.6 INCUBATORS 175
- 6.15.6.1 Rising demand for microbiological applications to drive market 175
6.15.7 FUME HOODS 176
- 6.15.7.1 Improvements in device structure to fuel market 176
6.15.8 ROBOTIC SYSTEMS 177
- 6.15.8.1 Technological advancements to support market 177
- 6.15.8.2 Robotic arms 178
- 6.15.8.3 Track robot systems 178
6.15.9 PH METERS 178
- 6.15.9.1 Applications in pharmaceutical and food & beverage industries to drive market 178
6.15.10 CONDUCTIVITY AND RESISTIVITY METERS 179
- 6.15.10.1 Efficient operation and low cost benefits to support market 179
6.15.11 DISSOLVED CO2 AND O2 METERS 180
- 6.15.11.1 Rising utilization in water testing to fuel market 180
6.15.12 TITRATORS 181
- 6.15.12.1 Quality control testing for industrial chemical applications to support market growth 181
6.15.13 GAS ANALYZERS 181
- 6.15.13.1 Utilization in iron and steel industries to support market growth 181
6.15.14 TOC ANALYZERS 182
- 6.15.14.1 Critical parameter for water testing & purification to drive market 182
6.15.15 THERMAL ANALYZERS 183
- 6.15.15.1 Applications in polymer & metal industries to fuel segment 183
6.15.16 SHAKERS/ROTATORS AND STIRRERS 184
- 6.15.16.1 Increasing research in pharmaceutical & biotechnology research to drive market 184
7 LIFE SCIENCE INSTRUMENTATION MARKET, BY APPLICATION 185
7.1 INTRODUCTION 186
7.2 RESEARCH APPLICATIONS 186
7.2.1 RISING RESEARCH ACTIVITIES IN DRUG DISCOVERY & BIOMARKER DEVELOPMENT TO FUEL MARKET 186
7.3 CLINICAL & DIAGNOSTIC APPLICATIONS 188
7.3.1 RISING PREVALENCE OF INFECTIOUS & TARGET DISEASES TO DRIVE MARKET 188
7.4 OTHER APPLICATIONS 190
8 LIFE SCIENCE INSTRUMENTATION MARKET, BY END USER 192
8.1 INTRODUCTION 193
8.2 HOSPITALS AND DIAGNOSTIC LABORATORIES 193
8.2.1 GROWING ADOPTION OF MOLECULAR DIAGNOSTICS TO DRIVE MARKET 193
8.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 194
8.3.1 GROWING FOCUS ON EXPANDING R&D FOR THERAPEUTIC DRUG PIPELINES TO DRIVE MARKET 194
8.4 ACADEMIC & RESEARCH INSTITUTES 195
8.4.1 INCREASING NUMBER OF CLINICAL TRIALS AND RESEARCH ACTIVITIES TO BOLSTER DEMAND FOR LIFE SCIENCE INSTRUMENTS 195
8.5 AGRICULTURE & FOOD INDUSTRIES 196
8.5.1 GROWING FOCUS ON FOOD SAFETY AND QUALITY CONTROL TO DRIVE MARKET 196
8.6 ENVIRONMENTAL TESTING LABORATORIES 197
8.6.1 INCREASING ADOPTION OF CHROMATOGRAPHY INSTRUMENTS FOR AIR QUALITY TESTING TO DRIVE MARKET 197
8.7 CLINICAL RESEARCH ORGANIZATIONS 198
8.7.1 OUTSOURCING OF R&D ACTIVITIES BY PHARMA & BIOTECH COMPANIES TO SUPPORT MARKET GROWTH 198
8.8 OTHER END USERS 199
9 LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION 200
9.1 INTRODUCTION 201
9.2 NORTH AMERICA 202
9.2.1 US 209
- 9.2.1.1 Increased presence of major pharmaceutical and biotechnology companies to drive market 209
9.2.2 CANADA 211
- 9.2.2.1 Increasing funding for genomic and clinical research to increase adoption of life science instrumentation technologies 211
9.3 EUROPE 212
9.3.1 GERMANY 219
- 9.3.1.1 Favorable reimbursement and insurance scenarios for various diagnostic tests to support market 219
9.3.2 UK 220
- 9.3.2.1 Rising number of research activities and academia-industry partnerships to propel market 220
9.3.3 FRANCE 222
- 9.3.3.1 Increasing investments in infrastructure development for life science R&D to fuel market 222
9.3.4 SPAIN 223
- 9.3.4.1 Growing focus on cancer research and advanced R&D structure to support market 223
9.3.5 ITALY 225
- 9.3.5.1 Growing advancements in biotechnology and increasing R&D investments by pharmaceutical companies to boost market 225
9.3.6 REST OF EUROPE 226
9.4 ASIA PACIFIC 227
9.4.1 JAPAN 235
- 9.4.1.1 Growing adoption of technologically advanced products to increase adoption of life science instruments 235
9.4.2 CHINA 237
- 9.4.2.1 Increasing production and export of pharmaceuticals to favor market growth 237
9.4.3 INDIA 238
- 9.4.3.1 Increasing healthcare expenditure and growing availability of advanced molecular diagnosis technology to drive market 238
9.4.4 AUSTRALIA 240
- 9.4.4.1 Rising healthcare spending, increasing cancer diagnostics, and growing agricultural research to augment market 240
9.4.5 SOUTH KOREA 241
- 9.4.5.1 High spending on research activities and developments in pharmaceutical drug discovery to positively influence market 241
9.4.6 REST OF ASIA PACIFIC 242
9.5 LATIN AMERICA 243
9.5.1 BRAZIL 250
- 9.5.1.1 Rising R&D activities and increasing growth in biologics sector to propel market 250
9.5.2 MEXICO 252
- 9.5.2.1 Presence of favorable business environment for market players to attract investment and drive market 252
9.5.3 REST OF LATIN AMERICA 253
9.6 MIDDLE EAST & AFRICA 254
9.6.1 INCREASING GOVERNMENT EXPENDITURE AND DEVELOPING HEALTHCARE INFRASTRUCTURE TO FUEL MARKET 254
10 COMPETITIVE LANDSCAPE 263
10.1 OVERVIEW 263
10.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY PLAYERS 263
10.3 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN LIFE SCIENCE INSTRUMENTATION MARKET 264
10.4 REVENUE SHARE ANALYSIS 265
10.5 MARKET SHARE ANALYSIS 265
10.5.1 MARKET SHARE ANALYSIS FOR SPECTROSCOPY 266
10.5.2 MARKET SHARE ANALYSIS FOR CHROMATOGRAPHY 266
10.5.3 MARKET SHARE ANALYSIS FOR PCR 267
10.5.4 MARKET SHARE ANALYSIS FOR NGS 267
10.6 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS (2022) 269
10.7 VENDOR INCLUSION CRITERIA 269
10.7.1 STARS 269
10.7.2 PERVASIVE PLAYERS 269
10.7.3 EMERGING LEADERS 269
10.7.4 PARTICIPANTS 269
10.8 COMPANY EVALUATION QUADRANT FOR SMES/START-UPS (2022) 271
10.8.1 PROGRESSIVE COMPANIES 271
10.8.2 STARTING BLOCKS 271
10.8.3 RESPONSIVE COMPANIES 271
10.8.4 DYNAMIC COMPANIES 271
10.9 COMPETITIVE BENCHMARKING 273
10.10 COMPETITIVE SCENARIO AND TRENDS 274
10.10.1 KEY PRODUCT LAUNCHES 274
10.10.2 KEY DEALS 277
10.10.3 OTHER KEY DEVELOPMENTS 281
11 COMPANY PROFILES 283
11.1 KEY PLAYERS 283
11.1.1 THERMO FISHER SCIENTIFIC INC 283
11.1.2 DANAHER CORPORATION 311
11.1.3 AGILENT TECHNOLOGIES, INC 319
11.1.4 WATERS CORPORATION 329
11.1.5 SHIMADZU CORPORATION 335
11.1.6 BECTON, DICKINSON AND COMPANY 345
11.1.7 PERKINELMER INC 350
11.1.8 BIO-RAD LABORATORIES, INC 358
11.1.9 BRUKER 364
11.1.10 QIAGEN N.V 371
11.1.11 EPPENDORF SE 376
11.1.12 HITACHI HIGH-TECHNOLOGIES CORPORATION 381
11.1.13 HORIBA, LTD 386
11.1.14 MERCK KGAA 392
11.1.15 JEOL LTD 398
11.2 OTHER COMPANIES 404
11.2.1 BIOMERIEUX S.A 404
11.2.2 CARL ZEISS AG 405
11.2.3 TECAN TRADING AG 406
11.2.4 SIGMA LABORZENTRIFUGEN GMBH 407
11.2.5 ILLUMINA, INC 407
11.2.6 AVANTOR, INC 408
11.2.7 OLYMPUS CORPORATION 409
11.2.8 OXFORD INSTRUMENTS 410
11.2.9 GILSON INCORPORATED 411
11.2.10 GL SCIENCES INC 411
11.2.11 ACCU-SCOPE 412
11.2.12 PANOMEX INC 413
11.2.13 CLEAVER SCIENTIFIC 414
11.2.14 MOTIC GROUP 415
11.2.15 HYRIS LTD 415
12 APPENDIX 416
12.1 DISCUSSION GUIDE 416
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 422
12.3 CUSTOMIZATION OPTIONS 424
12.4 RELATED REPORTS 424
12.5 AUTHOR DETAILS 426